INGITAMIG
UNII 6R6GWJ8GDZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Ingitamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6R6GWJ8GDZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2839572-09-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6R6GWJ8GDZ

CAS Registry Number

2839572-09-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INGITAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190202

National Cancer Institute reference terminology for clinical and research data.

INN ID

12958

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-96

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ingitamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INGITAMIG

Common Names & Synonyms

CC 92328 [WHO-DD]

IMMUNOGLOBULIN G1 (DE-446-LYSINE), BISPECIFIC, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN CLONE EECPSTF2CP165-CP14 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (SGSGGGGS) FUSION PROTEIN IMMUNOGLOBULIN ANTI-(HUMAN KILLER CELL LECTIN-LIKE RECEPTOR KLRK1) (HUMAN SINGLE-CHAIN VARIABLE FRAGMENT VL-(GGGGS)4-VH), DISULFIDE WITH HUMAN CLONE EECPSTF2CP165-CP14 .KAPPA.-CHAIN, DIMER

INGITAMIG [USAN]